Skip to main content

Table 5 Treatment outcomes in patients between group I and group II at 10 weeks

From: Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure

  Group I (AmB+ Group II (AmB+ P-value
Fluconazole + 5-FC,n = 27) Fluconazole + 5-FC + VPS, n = 39)
Lost to follow-up 0 (0.0%) 1 (2.3%) 0.399
Successful response 8 (29.6%) 22 (57.9%) 0.025*
 Complete response 3 (11.1%) 11 (28.9%)  
 Partial response 5 (18.5%) 11 (28.9%)  
Failure 19 (70.4%) 16 (42.1%) 0.350
 Stable response 15 (55.6%) 10 (26.3%)  
 Disease progression 4 (14.8%) 4 (10.5%)  
 Death 0 (0.0%) 2 (5.3%)  
  1. *p < 0.05